Manidipine Dihydrochloride

Cysolvia® is one of brands under Miedykol® a high-end and certified active pharmaceutical ingredients (APIs) and pharmaceutical intermediates manufacturer in China, mainly providing various APIs products and customized production (CMO/CDMO). We produce the manidipine dihydrochloride product—a novel type of dihydropyridines calcium channel blocker (CCB) selective for vasculature and does not yield effects on the heart at clinically relevant dosages. At Miedykol, we offer a broad range of mature or novel calcium channel blockers (CCBs) products utilized in oral tablets, injections and other dosage forms, serving as indispensable elements of therapy protocols for hypertension, arrhythmia, cardiovascular and cerebrovascular diseases. Reach out to us for further information.